Sigyn Therapeutics Inc Sustainability Reports
Sigyn Therapeutics, Inc. is a development-stage medical technology company focused on creating extracorporeal blood purification technologies. Its primary development candidate, Sigyn Therapy, is designed to treat pathogen-associated inflammatory disorders by reducing blood-borne toxins and cytokines.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
9 reports from 2015 to 2024